Entera Bio Ltd.
6 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Assess Safety and Compare PK of New Oral hPTH(1-34) Tablet Formulations vs. EBP05 Tablets and Subcutaneous Forteo (NCT05965167) | Entera Bio Ltd. | 2023-05-11 |
| Oral PTH(1-34) PK and PD Study in Patients With Hypoparathyroidism (NCT03516773) | Entera Bio Ltd. | 2018-06-17 |
Track Entera Bio Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.